Hi, what are you looking for?
By Sabela Ojea
LivaNova extended the term of Chairman William Kozy as interim chief executive until up to April 13, 2024.
The medical technology company announced the resignation of former CEO Damien McDonald in April.
Kozy will receive an additional one-time award of time-based restricted stock units valued at $750,000 effective Dec. 15, LivaNova said.
Write to Sabela Ojea at [email protected]; @sabelaojeaguix
Read the full article here
This article was written by Follow I like to take a long term, buy-and-hold approach to investing, with a bias toward stocks that can...
This article was written by Follow From Growth To Value (Kris) is an individual investor with a long-term perspective. He targets high-quality disruptive businesses...
